John A. Schetz

1.6k total citations
55 papers, 1.2k citations indexed

About

John A. Schetz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, John A. Schetz has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in John A. Schetz's work include Receptor Mechanisms and Signaling (25 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). John A. Schetz is often cited by papers focused on Receptor Mechanisms and Signaling (25 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (10 papers). John A. Schetz collaborates with scholars based in United States, Belgium and Switzerland. John A. Schetz's co-authors include David R. Sibley, M Verstraete, F De Cock, E. Holmer, D Collen, Harel Weinstein, Spencer S. Ericksen, Robert McMahon, Ivan T. Lee and Alice Chu and has published in prestigious journals such as The Journal of Immunology, Brain Research and The FASEB Journal.

In The Last Decade

John A. Schetz

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Schetz United States 22 607 422 132 115 89 55 1.2k
Thomas Schmitz Germany 28 544 0.9× 149 0.4× 57 0.4× 114 1.0× 48 0.5× 71 2.0k
Philippe Pradelles France 25 828 1.4× 397 0.9× 105 0.8× 37 0.3× 23 0.3× 55 1.7k
Alan Kosaka United States 16 544 0.9× 281 0.7× 41 0.3× 24 0.2× 14 0.2× 26 1.5k
Stefania Hanau Italy 21 764 1.3× 148 0.4× 97 0.7× 34 0.3× 21 0.2× 61 2.0k
P. Schelling Germany 28 968 1.6× 273 0.6× 102 0.8× 27 0.2× 10 0.1× 69 2.4k
Wenxin Li China 22 642 1.1× 61 0.1× 69 0.5× 27 0.2× 41 0.5× 114 1.7k
Keith M. Dawson United Kingdom 15 509 0.8× 100 0.2× 37 0.3× 60 0.5× 46 0.5× 47 1.4k
Germain Gillet France 29 1.3k 2.2× 188 0.4× 43 0.3× 34 0.3× 21 0.2× 81 2.2k
P. Donatsch Switzerland 19 927 1.5× 575 1.4× 94 0.7× 64 0.6× 5 0.1× 45 2.2k
Maria L. Webb United States 25 802 1.3× 182 0.4× 152 1.2× 62 0.5× 8 0.1× 93 1.9k

Countries citing papers authored by John A. Schetz

Since Specialization
Citations

This map shows the geographic impact of John A. Schetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Schetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Schetz more than expected).

Fields of papers citing papers by John A. Schetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Schetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Schetz. The network helps show where John A. Schetz may publish in the future.

Co-authorship network of co-authors of John A. Schetz

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Schetz. A scholar is included among the top collaborators of John A. Schetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Schetz. John A. Schetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey, Brian H., et al.. (2018). Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs. Pharmacological Reviews. 70(3). 684–711. 46 indexed citations
2.
Kim, Seongcheol, et al.. (2017). Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia. Neurochemistry International. 105. 21–31. 21 indexed citations
3.
Huang, Renqi, Zhenglan Chen, Sean B. Dolan, John A. Schetz, & Glenn H. Dillon. (2017). The dual modulatory effects of efavirenz on GABA A receptors are mediated via two distinct sites. Neuropharmacology. 121. 167–178. 5 indexed citations
4.
Gatch, Michael B., Alexey Kozlenkov, Jacques D. Nguyen, et al.. (2013). The HIV Antiretroviral Drug Efavirenz has LSD-Like Properties. Neuropsychopharmacology. 38(12). 2373–2384. 66 indexed citations
5.
Ericksen, Spencer S., et al.. (2012). Ring Substituents on Substituted Benzamide Ligands Indirectly Mediate Interactions with Position 7.39 of Transmembrane Helix 7 of the D4 Dopamine Receptor. Journal of Pharmacology and Experimental Therapeutics. 342(2). 472–485. 7 indexed citations
6.
Voulalas, Pamela J., John A. Schetz, & Ashiwel S. Undieh. (2011). Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine. Molecular and Cellular Neuroscience. 46(3). 645–654. 27 indexed citations
7.
8.
Ericksen, Spencer S., et al.. (2010). Transmembrane Segment Five Serines of the D4 Dopamine Receptor Uniquely Influence the Interactions of Dopamine, Norepinephrine, and Ro10-4548. Journal of Pharmacology and Experimental Therapeutics. 333(3). 682–695. 21 indexed citations
9.
Chang, Chiung-Wen, Ethan Poteet, John A. Schetz, Zeynep H. Gümüş, & Harel Weinstein. (2008). Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation. Neuropharmacology. 56. 213–225. 21 indexed citations
10.
Schetz, John A., et al.. (2007). A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Research. 1181. 1–9. 45 indexed citations
11.
12.
13.
Schetz, John A.. (2005). Allosteric Modulation of Dopamine Receptors. Mini-Reviews in Medicinal Chemistry. 5(6). 555–561. 21 indexed citations
14.
Kortagere, Sandhya, Peter Gmeiner, Harel Weinstein, & John A. Schetz. (2004). Certain 1,4-Disubstituted Aromatic Piperidines and Piperazines with Extreme Selectivity for the Dopamine D4 Receptor Interact with a Common Receptor Microdomain. Molecular Pharmacology. 66(6). 1491–1499. 33 indexed citations
15.
Schetz, John A., Okjin Kim, & David R. Sibley. (2003). Pharmacological Characterization of Mammalian D1and D2Dopamine Receptors Expressed inDrosophilaSchneider‐2 Cells. Journal of Receptors and Signal Transduction. 23(1). 99–109. 10 indexed citations
16.
Hu, Jin‐Feng, John A. Schetz, Michelle Kelly, et al.. (2002). New Antiinfective and Human 5-HT2 Receptor Binding Natural and Semisynthetic Compounds from the Jamaican Sponge Smenospongia aurea. Journal of Natural Products. 65(4). 476–480. 100 indexed citations
17.
18.
Schetz, John A. & David R. Sibley. (2000). Tandem sulfur-containing amino acids are epicritical determinants of dopamine D2 receptor pharmacology. European Journal of Pharmacology. 388(2). R5–R7. 2 indexed citations
19.
Woodhouse, Elisa C., Derek F. Amanatullah, John A. Schetz, et al.. (1998). Adenosine Receptor Mediates Motility in Human Melanoma Cells. Biochemical and Biophysical Research Communications. 246(3). 888–894. 53 indexed citations
20.
Schetz, John A. & Peter Anderson. (1995). Glycosylation patterns of membrane proteins of the jellyfish Cyanea capillata. Cell and Tissue Research. 279(2). 315–321. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Schmitz Breakdown of academic impact, for papers by Philippe Pradelles Breakdown of academic impact, for papers by Alan Kosaka Breakdown of academic impact, for papers by Stefania Hanau Breakdown of academic impact, for papers by P. Schelling Breakdown of academic impact, for papers by Wenxin Li Breakdown of academic impact, for papers by Keith M. Dawson Breakdown of academic impact, for papers by Germain Gillet Breakdown of academic impact, for papers by P. Donatsch Breakdown of academic impact, for papers by Maria L. Webb
Rankless by CCL
2026